Literature DB >> 20093607

Usefulness of diffusion-weighted imaging in the evaluation of renal masses.

Kumaresan Sandrasegaran1, Chandru P Sundaram, Raja Ramaswamy, Fatih M Akisik, Magnus P Rydberg, Chen Lin, Alex M Aisen.   

Abstract

OBJECTIVE: The objective of our study was to assess the value of diffusion-weighted imaging in differentiating among the various subgroups of renal masses.
MATERIALS AND METHODS: This retrospective study measured the apparent diffusion coefficients (ADCs) of renal masses. Malignant lesions were confirmed with surgical pathology results. Benign cystic lesions were stable without treatment for a minimum follow-up of 24 months.
RESULTS: There were 20 and 22 patients, respectively, with benign lesions (three abscess, 31 cysts) and malignant lesions (17 clear cell, five papillary, one chromophobe, and two transitional cell cancers). The malignant lesions were larger than the benign lesions (mean diameter, 4.2 vs 2.6 cm, respectively; p = 0.01, Student's t test). The ADC values of the benign lesions were significantly higher than those of the malignant lesions (mean, 2.72 vs 1.88 x 10(-3) mm(2)/s; p < 0.0001). The ADCs of the 31 benign cysts were significantly higher than those of the seven cystic renal cancers (2.77 vs 2.02 x 10(-3) mm(2)/s; p < 0.001). There was no significant difference between the ADCs of clear cell cancers and non-clear cell cancers (1.85 vs 1.97 x 10(-3) mm(2)/s; p = 0.18), but an ADC of less than 1.79 x 10(-3) mm(2)/s was seen only with clear cell cancer. The ADCs of high-grade clear cell cancers (Fuhrman grades III and IV) tended to be lower than those of low-grade clear cell cancers (1.77 vs 1.95 x 10(-3) mm(2)/s; p = 0.12). Among the clear cell cancers, an ADC value of greater than 2.12 x 10(-3) mm(2)/s was seen only with low-grade histology. For differentiating benign from malignant lesions, receiver operating characteristic (ROC) analysis showed an area under the ROC curve of 0.989 (95% CI, 0.919-0.996; p < 0.0001).
CONCLUSION: ADC measurements may aid in differentiating among the various subgroups of renal masses, particularly benign cystic lesions from cystic renal cell cancers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093607     DOI: 10.2214/AJR.09.3024

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  56 in total

Review 1.  Renal angiomyolipoma without visible fat: Can we make the diagnosis using CT and MRI?

Authors:  Robert S Lim; Trevor A Flood; Matthew D F McInnes; Luke T Lavallee; Nicola Schieda
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

Review 2.  [Functional magnetic resonance imaging of the kidneys].

Authors:  R S Lanzman; M Notohamiprodjo; H J Wittsack
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

Review 3.  Diffusion-weighted MRI of renal cell carcinoma, upper tract urothelial carcinoma, and renal infection: a pictorial review.

Authors:  Jonathan R Cogley; Dustin D Nguyen; Peter M Ghobrial; Dmitry Rakita
Journal:  Jpn J Radiol       Date:  2013-09-03       Impact factor: 2.374

4.  Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.

Authors:  Yan Zhong; Haiyi Wang; Yanguang Shen; Aitao Guo; Jia Wang; Suhai Kang; Lu Ma; Jingjing Pan; Huiyi Ye
Journal:  Eur Radiol       Date:  2017-06-19       Impact factor: 5.315

Review 5.  Imaging renal cell carcinoma with ultrasonography, CT and MRI.

Authors:  Michael J Leveridge; Peter J Bostrom; George Koulouris; Antonio Finelli; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-05-18       Impact factor: 14.432

Review 6.  Targeted therapies in renal cell cancer: recent developments in imaging.

Authors:  Astrid A M van der Veldt; Martijn R Meijerink; Alfons J M van den Eertwegh; Epie Boven
Journal:  Target Oncol       Date:  2010-07-14       Impact factor: 4.493

7.  Predicting common solid renal tumors using machine learning models of classification of radiologist-assessed magnetic resonance characteristics.

Authors:  Camila Lopes Vendrami; Robert J McCarthy; Carolina Parada Villavicencio; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2020-07-14

8.  Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade.

Authors:  Hebert Alberto Vargas; Holly G Delaney; Eithne M Delappe; Ya Wang; Junting Zheng; Chaya S Moskowitz; Yongqiang Tan; Binsheng Zhao; Lawrence H Schwartz; Hedvig Hricak; Paul Russo; Oguz Akin
Journal:  J Magn Reson Imaging       Date:  2012-11-13       Impact factor: 4.813

9.  Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity.

Authors:  Qing Yuan; Payal Kapur; Yue Zhang; Yin Xi; Ingrid Carvo; Sabina Signoretti; Ivan E Dimitrov; Jeffrey A Cadeddu; Vitaly Margulis; James Brugarolas; Ananth J Madhuranthakam; Ivan Pedrosa
Journal:  Clin Genitourin Cancer       Date:  2016-04-22       Impact factor: 2.872

10.  Evaluation of cancer treatment in the abdomen: Trends and advances.

Authors:  Silanath Peungjesada; Hubert H Chuang; Srinivasa R Prasad; Haesun Choi; Evelyne M Loyer; Yulia Bronstein
Journal:  World J Radiol       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.